Dr. Shibani Ramchandran

Qualifications

• Bachelor of Physiotherapy (BPTh)
• Executive Management Development Programme (eMDP) in Healthcare Management & Data Analytics
• Certified Medical Writer

Areas of Expertise

Work Experience / Professional Background

Dr. Shibani Ramchandran is a healthcare professional, certified medical writer and scientific affairs specialist with 11 years of clinical experience. She currently serves as Lead, Scientific Affairs & Medical Writing at Metropolis Healthcare Ltd.

She completed her Bachelor of Physiotherapy (BPTh) from Topiwala National Medical College & BYL Nair Hospital, Mumbai, affiliated with Maharashtra University of Health Sciences (MUHS). She further pursued an Executive Management Development Programme (eMDP) in Healthcare Management & Data Analytics from the Indian Institute of Management Kozhikode (IIM-K) and holds a professional certification in medical writing.

Her clinical background includes experience as a Consultant Physiotherapist at BYL Nair Hospital, Mumbai, and Portea Medical & Home Healthcare Services, Mumbai. Her clinical expertise encompasses physical rehabilitation, neurorehabilitation, post-surgical rehabilitation and chronic disease management.

In her current role, she specializes in scientific affairs and medical writing across multiple therapeutic areas, including chronic diseases, neurology, oncology, and women's and child health. Her professional experience includes Key Opinion Leader (KOL) engagement, scientific publications, professional training and skill enhancement.

Her contributions to scientific publications span hematology, oncology, neurological disorders and metabolic health, including research related to thalassemia, leukemia, lung and breast cancer, neuroimmunological disorders and dyslipidemia in prediabetes.

She has also completed an academic capstone project focused on diabetes monitoring and management as part of her executive management programme at IIM Kozhikode, complementing her clinical and scientific expertise with knowledge of healthcare management and data analytics.

Research & Publications

1. Sudke SH, Halder M, Jatale R, Ramchandran S, Suryanarayan A. Thalassemia and hemoglobinopathies in pediatric populations: Prevalence, diagnostic insights, and regional patterns. Clinical Medicine and Health Research Journal. 2025;5(2):1241-1247. https://doi.org/10.18535/cmhrj.v5i02.460
2. Singh N, Gohil S, Mathias J, Haryan R, Dhole S, Ramchandran S, et al. Flowcytometry immunophenotyping: Role in acute leukemia and detection of aberrant expressions in the Indian population. Asian Hematology Research Journal. 2024;7(2):83-95. https://journalahrj.com/index.php/AHRJ/article/view/171
3. Munde S, Barodawala S, Lila K, Jatale R, Ramchandran S, Chanekar M, et al. Molecular analysis for EGFR, ALK, and ROS1 alterations in over 3000 Indian patients with non-small-cell lung cancer: A retrospective observational study. Cancer Res Stat Treat. 2024;7(1):11-18. https://doi.org/10.4103/crst.crst_314_23
4. Barodawala S, Lila K, Chadha K, Pradhan G, Parab P, Jatale R, Ramchandran S. Immunohistochemical characterization of breast carcinoma: Clinical correlations, molecular subtypes, and therapeutic implications. Arch Breast Cancer. 2024 May 1;11(2):108-117. https://archbreastcancer.com/index.php/abc/article/view/901
5. Almeida FJ, Christy A, Jatale R, Ramchandran S. Prevalence of autoantibodies neuromyelitis optica (NMO IgG) and myelin oligodendrocyte glycoprotein (MOG) in NMOSD and the relationship between them in the general population. IP Indian J Neurosci. 2024;10(4):190-196. https://doi.org/10.18231/j.ijn.2024.041
6. Sundharan S, Ramchandran S, Jatale R, Chadha K. Dyslipidemia in prediabetes population: A retrospective study of 91780 cases. Int J Health Sci Res. 2022;12(10):132-139. https://doi.org/10.52403/ijhsr.20221017